The Global Intravenous (IV) Therapy and Vein Access Market is poised to grow at a CAGR of around 7.3% over the next decade to reach approximately $33.91 billion by 2025. Some of the prominent trends that the market is witnessing include rise in surgical method volumes and growing number of road accidents.
Based on medical application the market is categorized into medication administration, nutrition and buffer solution, volume expanders and blood based products.
By product, market is segregated by intravenous catheter, infusion pumps, implantable port, hypodermic needles and other products. Intravenous Catheter segment is further sub segmented into central intravenous catheter, peripherally inserted central catheter and peripheral intravenous catheter. Implantable port divided into double lumen implantable port and single lumen implantable port.
The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors.
Rise in surgical method volumes
Growing number of road accidents
Recent technological developments in Intravenous (IV) Therapy and Vein Access
Terumo Medical Corporation
BRIEF-Sichuan Kelun Pharmaceutical Co. Ltd.
Baxter International Inc.
Becton, Dickinson and Company
Teleflex Medical Inc.
CVS Health Corporation
Smith & Nephew plc
B. Braun Melsungen AG
Vifor Pharma Group
Key Topics Covered:
1 Market Outline
2 Executive Summary
3 Market Overview
4 Intravenous (IV) Therapy and Vein Access Market, By Medical Application
5 Intravenous (IV) Therapy and Vein Access Market, By End User
6 Intravenous (IV) Therapy and Vein Access Market, By Product
7 Intravenous (IV) Therapy and Vein Access Market, By Geography